Skip to content

Clinical value of gastric filling ultrasound based on exploring the addition and subtraction of Liver and Stomach Lily Soup on gastric motility in patients with post-stroke gastrointestinal dysfunction

Clinical value of gastric filling ultrasound based on exploring the addition and subtraction of Liver and Stomach Lily Soup on gastric motility in patients with post-stroke gastrointestinal dysfunction

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098667
Enrollment
Unknown
Registered
2025-03-12
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke gastrointestinal dysfunction

Interventions

Post-stroke gastrointestinal dysfunction patient group:Liver and Stomach Lily Soup Plus Reduction Treatment

Sponsors

Department of Rehabilitation Medicine, Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the modern medical diagnostic standards for stroke: according to the diagnostic criteria for cerebral infarction and cerebral hemorrhage in the Guidelines for the Prevention and Treatment of Cerebrovascular Diseases in China formulated by the Department of Disease Control of the Ministry of Health and the Neurology Branch of the Chinese Medical Association in 2010. 2. Meet the diagnostic criteria for gastrointestinal dysfunction 3. Meet the diagnostic criteria for gastric ruffian-liver and stomach disharmony in traditional Chinese medicine (refer to the "Expert Consensus on the Diagnosis and Treatment of Ruffian Traditional Chinese Medicine" formulated by the Spleen and Stomach Disease Branch of the Chinese Association of Chinese Medicine in 2023). 4. Age> 18 years old. 5. The course of the disease > 48 hours and the < 6 months. 6. No drugs affecting gastrointestinal motility have been used in the 3 days before the test. 7. Conscious, can cooperate with the completion of TCM syndrome assessment and Hamilton anxiety scale assessment. 8. There has been no adverse allergic reaction to Chinese herbal medicine. 9. Agree to sign the informed consent form for this clinical study.

Exclusion criteria

Exclusion criteria: 1. Those who refuse to participate in this study. 2. Patients with severe gastrointestinal impairment such as gastrointestinal obstruction, bleeding, gastrointestinal surgery, and malignant tumors. 3. Pregnant women and patients after cesarean section. 4. Patients with severe organ dysfunction. 5. Patients with severe abdominal distention, obesity, abdominal wall deformity, etc., who cannot undergo abdominal ultrasound. 6. The patient's medical record data is incomplete and cannot be collected.

Design outcomes

Primary

MeasureTime frame
gastric emptying rate;

Secondary

MeasureTime frame
motility index;Chinese Medicine Score;

Countries

China

Contacts

Public ContactShan Linlin

Shenzhen Second People's Hospital

8995327@qq.com+86 136 3261 0903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026